Mergers and Acquisitions

MAQUET Cardiopulmonary, has announced that it has signed an agreement with Avalon Laboratories to acquire its Avalon Elite® Bi-Caval Dual Lumen Catheter and complimentary vascular access kits for use during Extracorporeal Life Support.

3D Systems Corporation has announced that it has acquired San Francisco start-up Bespoke Innovations™, Inc. Bespoke develops proprietary, integrated scan, design and print technology that is designed to deliver custom fit prosthetics, orthotics and orthopedic devices that improve treatment and lifestyle outcomes.

Elsevier Business Intelligence (EBI), publisher of “The Gray Sheet”, is holding its IN³ Medical Device 360° at the Hyatt Regency Boston, June 27-29 2012.

It’s only a month or so since tissue processing and medical device company Cryolife coughed up $22M to acquire Cardiogenesis Corporation. Now the Atlanta based company has announced that it is to acquire Hemosphere Inc., manufacturer of the HeRO® Graft.

Covidien told us in March it was to acquire Israeli company superDimension. The deal is now done in a transaction worth $300M plus earnouts.

Smith & Nephew, Inc. acquires Kalypto Medical, Inc., further investing in Negative Pressure Wound Therapy to deliver continual innovation

The First Medical Device Acquisition in China for the Johnson & Johnson Family of Companies is Guangzho Bioseal Who’s Biologic Product Complements J&J’s Existing Haemostat Portfolio.

We didn’t see this one coming. Royal DSM, which describes itself as a life sciences and material sciences company, sees a great strategic fit with regenerative medicine specialist Kensey Nash, which has encouraged the Dutch based outfit to stump up a number well ahead of the current share price.

Not many weeks go by without news of a Covidien acquisition, so its not too surprising when the tech titan takes a shine to a company who’s product can help place its hernia meshes in a speedy and effective fashion.

Orthofix’s foray into bracing and cold therapy is over with its announcement that it’s selling Breg, acquired in 2003.

CareFusion continues its “simplify and focus” strategy with divestment of its Nicolet business to Natus Medical for a reported $58M.

There was an inevitability about the whole thing, but still J&J and Synthes execs must be relieved that the EU commission into their mega deal has agreed to the takeover following J&J’s concessionary divestiture of its existing trauma business. Wonder how those guys are feeling though.

Foillowing its acquisition of General Biotechnology LLC, Cook Group has announced its formation of Cook General Biotechnology LLC, in a move which will help reinforce its position in the cellular therapy field.

What an interesting deal. J&J’s Ethicon, not known for its soft negotiating stance, has agreed a deal in which it pays Angiotech for IP relating to the company’s Quill suture technology, yet is allowing the pharma company to keep on selling it.

The medical devices giant that is Covidien, shows its still on the acquisition trail with the announcement that it is to spend $300M buying Israeli respiratory monitoring company Oridion.

Biomet has an exclusive, binding offer of $280M on the table for J&J’s DePuy Trauma division. The deal is thought to represent J&J’s concession, extracted from the leviathan by an EU commission, in order to ratify its $21Bn takeover of Synthes.